NXL New Plan Excel Realty Trust, I

-

New Plan Excel Realty Trust, I Missed Consensus Estimates

Thursday, November 12, 2026 · 12:00 AM ET

New Plan Excel Realty Trust, I (NXL) reported a loss of $3.43 per share on revenue of $0.08 million for the third quarter ended September 2026. The consensus estimate was a loss of $2.91 per share on revenue of $0.08 million. The company missed consensus estimates by 17.87% while revenue grew 333.33% on a year-over-year basis.

Nexalin Technology Inc. designs and develops neurostimulation products for mental health epidemic. It licenses and markets Nexalin Device, a non-invasive and drug-free therapy for the treatment of anxiety and insomnia. Nexalin Technology Inc. is based in Houston, Texas.

Earnings Whisper Grade
Power Rating
Reported Earnings
($3.43)
Earnings Whisper®
—
Consensus Estimate
($2.91)
Earnings Surprise
Earnings Growth12.1 %
Reported Revenue
$0.08M
Revenue Estimate
$0.08M
Revenue Surprise
Revenue Growth333.3 %

*Reported earnings and revenue figures shown above, and any guidance given, are preliminary and may be updated upon further review.*